Browse Category

Stock Market News 22 January 2026

Stock market today: Trump’s Greenland tariff U-turn lifts Dow futures and Europe shares

Stock market today: Trump’s Greenland tariff U-turn lifts Dow futures and Europe shares

U.S. stock index futures rose early Thursday after President Trump dropped plans for tariffs linked to Greenland, with S&P 500 e-minis up 0.60%, Nasdaq 100 e-minis up 0.87%, and Dow e-minis up 0.41%. European shares rebounded and volatility eased following steep losses earlier in the week. Investors are focused on upcoming U.S. PCE inflation data and a Federal Reserve meeting next week.
22 January 2026
Dow snaps back after Trump cools Greenland tariff threat; Asia rallies and gold slips from record

Dow snaps back after Trump cools Greenland tariff threat; Asia rallies and gold slips from record

Wall Street posted its strongest session in two months Wednesday after President Trump dropped tariff threats linked to Greenland, sending the S&P 500 up 1.16% and the Dow higher by 588 points. Asian markets followed, with South Korea’s Kospi briefly topping 5,000. Gold retreated from record highs as volatility eased. European shares and the euro also gained as investors awaited central bank decisions and key earnings.
AST SpaceMobile stock rises in premarket as BlueBird 7 gets late-February New Glenn launch window

AST SpaceMobile stock rises in premarket as BlueBird 7 gets late-February New Glenn launch window

AST SpaceMobile shares rose 3.1% to $106.75 in premarket trading Thursday after the company scheduled its BlueBird 7 satellite launch for late February aboard Blue Origin’s New Glenn-3 rocket. The stock had dropped nearly 8% the previous day. Blue Origin also announced its own TeraWave satellite system, intensifying competition in the sector.
Lemonade stock rises again premarket as Tesla FSD insurance discount grabs attention

Lemonade stock rises again premarket as Tesla FSD insurance discount grabs attention

Lemonade shares rose 2.5% to $87.50 in premarket trading Thursday after a 9.1% jump Wednesday, following the launch of an “Autonomous Car” insurance policy for Tesla vehicles using Full Self-Driving. JPMorgan disclosed a 5.9% stake in the insurer. The new product rolls out in Arizona Jan. 26, with plans to expand to Oregon.
Micron stock pops in premarket as new Wall Street call lands amid a memory-price squeeze

Micron stock pops in premarket as new Wall Street call lands amid a memory-price squeeze

Micron shares rose 2.2% to $397.75 premarket Thursday after William Blair upgraded the stock to “Outperform,” following a 6.6% surge Wednesday. Memory-chip prices are spiking amid AI demand, with some products up 1,000%, raising concerns that higher costs could curb PC and smartphone shipments. Micron plans to buy Powerchip’s P5 fab in Taiwan for $1.8 billion, aiming to boost DRAM output by late 2027.
Lithium price jumps again as China spot hits 164,500 yuan; Albemarle in focus before U.S. open

Lithium price jumps again as China spot hits 164,500 yuan; Albemarle in focus before U.S. open

China’s battery-grade lithium carbonate price rose 3.8% to 164,500 yuan per ton on Thursday, extending its rebound. The Guangzhou Futures Exchange widened daily trading limits after repeated volatility. Albemarle shares gained 4.3% in U.S. trading Wednesday, while lithium ETF prices also climbed. Beijing will cut battery export VAT rebates from April, prompting expectations of increased near-term demand.
GE Aerospace earnings beat: 2026 profit forecast tops estimates as airlines keep engines in the shop

GE Aerospace earnings beat: 2026 profit forecast tops estimates as airlines keep engines in the shop

GE Aerospace forecast 2026 adjusted EPS of $7.10 to $7.40, above Wall Street estimates, citing strong demand for parts and maintenance as airlines keep older planes flying. Fourth-quarter adjusted EPS rose to $1.57, with revenue up 20% to $11.9 billion. Shares jumped nearly 4% premarket. GE reported a $190 billion backlog and record LEAP engine deliveries.
AI stocks today: Intel earnings, Nvidia export vote and rising memory prices in focus

AI stocks today: Intel earnings, Nvidia export vote and rising memory prices in focus

Intel jumped 11.7% to $54.25 Wednesday, leading gains among AI chipmakers ahead of its quarterly report; Nvidia rose 3%, AMD 7.6%, and Micron 6.6%. Compal warned memory costs could reach up to 40% of PC component prices due to surging demand. The U.S. House advanced a bill to tighten AI chip exports, targeting Nvidia’s Blackwell chips. The S&P 500 rose 1.16% after Trump’s Greenland deal and tariff pause.
Dow Jones futures edge higher after tariff U-turn; GDP and PCE inflation data ahead

Dow Jones futures edge higher after tariff U-turn; GDP and PCE inflation data ahead

Dow Jones futures rose 61 points premarket after the index jumped 588.64 points Wednesday, following President Trump’s decision to halt planned tariffs tied to a Greenland deal. Investors await key GDP and jobless claims data at 8:30 a.m. ET, with Procter & Gamble earnings due before the bell. Markets remain sensitive to tariff headlines and political developments in Washington.
FTSE 100 climbs as Trump cools tariff row; Beazley bid and BoE bets steer UK stocks

FTSE 100 climbs as Trump cools tariff row; Beazley bid and BoE bets steer UK stocks

The FTSE 100 rose 0.7% to 10,212.91 by 1104 GMT, as risk appetite improved after President Trump eased tariff threats against European NATO allies. Senior shares jumped 8.3% on a profit outlook upgrade, while Beazley fell 1% after rejecting a Zurich Insurance bid. JD Sports reported a 1.8% drop in like-for-like sales and warned of muted growth ahead.
Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal founder Deepinder Goyal will step down as CEO on Feb. 1, with Blinkit head Albinder Dhindsa taking over. Dr Reddy’s won approval to sell a generic Ozempic in India and plans to launch 12 million semaglutide pens in the first year. Waaree Energies more than doubled its profit, while HPCL and Bank of India also reported higher earnings for the quarter.
22 January 2026
India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

Sensex rose 0.49% and Nifty 50 gained 0.53% on Thursday, ending a three-day decline after U.S. President Trump eased tariff threats. The rupee closed at 91.63 per dollar, rebounding from a record low. Dr Reddy’s surged 5.2% after regulatory approval for a generic Ozempic, while Eternal fell 2.7%. The Reserve Bank of India conducted over $2 billion in FX swaps to support liquidity.
22 January 2026
ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

Australia’s S&P/ASX 200 rose 0.8% to 8,849, snapping a three-day losing streak, as energy and banks advanced but miners fell 1.6%. Santos and South32 each gained about 5%, while Northern Star dropped 8.8% on weak results. The unemployment rate fell to 4.1% and jobs surged by 65,200, lifting rate hike bets. AUSTRAC ordered an external audit of Airwallex over anti-money laundering concerns.
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed shares dropped 3.4% to $11.64 in premarket trading Thursday, following a 94.7% surge the previous session after its Lucid Diagnostics unit secured a U.S. Veterans Affairs contract for the EsoGuard test. Lucid shares fell 10.6% premarket. Investors are seeking details on test rollout and volumes. PAVmed recently completed a 1-for-30 reverse stock split to meet Nasdaq requirements.

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop